Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'Deeks, SG' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 29 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Deeks, SG; Barditch-Crovo, P; Collier, A; Smith, A; Miller, M; McGowan, M; Coakley, DF
      Hydroxyurea does not enhance the anti-HIV activity of low-dose tenofovir disoproxil fumarate

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    2. Deeks, SG
      Nonnucleoside reverse transcriptase inhibitor resistance

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    3. Stoddart, CA; Liegler, TJ; Mammano, F; Linquist-Stepps, VD; Hayden, MS; Deeks, SG; Grant, RM; Clavel, F; McCune, JM
      Impaired replication of protease inhibitor-resistant HIV-1 in human thymus

      NATURE MEDICINE
    4. Napolitano, LA; Grant, RM; Deeks, SG; Schmidt, D; De Rosa, SC; Herzenberg, LA; Herndier, BG; Andersson, J; McCune, JM
      Increased production of IL-7 accompanies HIV-l-mediated T-cell depletion: implications for T-cell homeostasis

      NATURE MEDICINE
    5. Penn, ML; Myers, M; Eckstein, DA; Liegler, TJ; Hayden, M; Mammano, F; Clavel, F; Deeks, SG; Grant, RM; Goldsmith, MA
      Primary and recombinant HIV type 1 strains resistant to protease inhibitors are pathogenic in mature human lymphoid tissues

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    6. Liegler, TJ; Hayden, MS; Lee, KH; Hoh, R; Deeks, SG; Grant, RM
      Protease inhibitor-resistant HIV-1 from patients with preserved CD4 cell counts is cytopathic in activated CD4 T lymphocytes

      AIDS
    7. Price, RW; Paxinos, EE; Grant, RM; Drews, B; Nilsson, A; Hoh, R; Hellmann, NS; Petropoulos, CJ; Deeks, SG
      Cerebrospinal fluid response to structured treatment interruption after virological failure

      AIDS
    8. Deeks, SG; Martin, JN
      Reassessing the goal of antiretroviral therapy in the heavily pre-treated HIV-infected patient

      AIDS
    9. Deeks, SG
      Durable HIV treatment benefit despite low-level viremia - Reassessing definitions of success or failure

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    10. Barditch-Crovo, P; Deeks, SG; Collier, A; Safrin, S; Coakley, DF; Miller, M; Kearney, BP; Coleman, RL; Lamy, PD; Kahn, JO; McGowan, I; Lietman, PS
      Phase I/II trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    11. Deeks, SG; Wrin, T; Liegler, T; Hoh, R; Hayden, M; Barbour, JD; Hellmann, NS; Petropoulos, CJ; McCune, JM; Hellerstein, MK; Grant, RM
      Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.

      NEW ENGLAND JOURNAL OF MEDICINE
    12. Huang, SS; Barbour, JD; Deeks, SG; Huang, JS; Grant, RM; Ng, VL; McCune, JM
      Reversal of human immunodeficiency virus type 1 - Associated hematosuppression by effective antiretroviral therapy

      CLINICAL INFECTIOUS DISEASES
    13. Deeks, SG
      Determinants of virological response to antiretroviral therapy: Implications for long-term strategies

      CLINICAL INFECTIOUS DISEASES
    14. Parkin, NT; Deeks, SG; Wrin, MT; Yap, J; Grant, RM; Lee, KH; Heeren, D; Hellmann, NS; Petropoulos, CJ
      Loss of antiretroviral drug susceptibility at low viral load during early virological failure in treatment-experienced patients

      AIDS
    15. Deeks, SG; Barbour, JD; Martin, JN; Swanson, MS; Grant, RM
      Sustained CD4(+) T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection

      JOURNAL OF INFECTIOUS DISEASES
    16. Mitsuyasu, RT; Anton, PA; Deeks, SG; Scadden, DT; Connick, E; Downs, MT; Bakker, A; Roberts, MR; June, CH; Jalali, S; Lin, AA; Pennathur-Das, R; Hege, KM
      Prolonged survival and tissue trafficking following adoptive transfer of CD4 zeta gene-modified autologous CD4(+) and CD8(+) T cells in human immunodeficiency virus-infected subjects

      BLOOD
    17. Deeks, SG; Grant, RM
      Sustained CD4 responses after virological failure of protease inhibitor-containing therapy

      ANTIVIRAL THERAPY
    18. Deeks, SG; Hecht, FM; Swanson, M; Elbeik, T; Loftus, R; Cohen, PT; Grant, RM
      HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: Response to both initial and salvage therapy

      AIDS
    19. Deeks, SG; Hellmann, NS; Grant, RM; Parkin, NT; Petropoulos, CJ; Becker, M; Symonds, W; Chesney, M; Volberding, PA
      Novel four-drug salvage treatment regimens after failure of a human immunodeficiency virus type 1 protease inhibitor-containing regimen: Antiviral activity and correlation of baseline phenotypic drug susceptibility with virologic outcome

      JOURNAL OF INFECTIOUS DISEASES
    20. DEEKS SG; GRANT RM; BEATTY GW; HORTON C; DETMER J; EASTMAN S
      ACTIVITY OF A RITONAVIR PLUS SAQUINAVIR-CONTAINING REGIMEN IN PATIENTS WITH VIROLOGICAL EVIDENCE OF INDINAVIR OR RITONAVIR FAILURE

      AIDS
    21. VOLBERDING PA; DEEKS SG
      ANTIRETROVIRAL THERAPY FOR HIV-INFECTION - PROMISES AND PROBLEMS

      JAMA, the journal of the American Medical Association
    22. DEEKS SG
      PRACTICAL ISSUES REGARDING THE USE OF ANTIRETROVIRAL THERAPY FOR HIV-INFECTION

      Western journal of medicine
    23. DEEKS SG; BARDITCHCROVO P; LIETMAN PS; HWANG F; CUNDY KC; ROONEY JF; HELLMANN NS; SAFRIN S; KAHN JO
      SAFETY, PHARMACOKINETICS, AND ANTIRETROVIRAL ACTIVITY OF INTRAVENOUS 9-[2-(R)-(PHOSPHONOMETHOXY)PROPYL]ADENINE A NOVEL ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) THERAPY, IN HIV-INFECTED ADULTS

      Antimicrobial agents and chemotherapy
    24. DEEKS SG; COLEMAN RL
      COMPARISON OF 3 CLINICAL GUIDELINES FOR THE USE OF ANTIRETROVIRAL THERAPIES

      Formulary
    25. DEEKS SG; ABRAMS DI
      GENOTYPIC-RESISTANCE ASSAYS AND ANTIRETROVIRAL THERAPY

      Lancet
    26. DEEKS SG; SMITH M; HOLODNIY M; KAHN JO
      HIV-1 PROTEASE INHIBITORS - A REVIEW FOR CLINICIAN

      JAMA, the journal of the American Medical Association
    27. DEEKS SG; COLLIER A; LALEZARI J; PAVIA A; RODRIGUE D; DREW WL; TOOLE J; JAFFE HS; MULATO AS; LAMY PD; LI WX; CHERRINGTON JM; HELLMANN N; KAHN J
      THE SAFETY AND EFFICACY OF ADEFOVIR DIPIVOXIL, A NOVEL ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) THERAPY, IN HIV-INFECTED ADULTS - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

      The Journal of infectious diseases
    28. DEEKS SG; COLEMAN RL; WHITE R; PACHL C; SCHAMBELAN M; CHERNOFF DN; FEINBERG MB
      VARIANCE OF PLASMA HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA LEVELS MEASURED BY BRANCHED DNA WITHIN AND BETWEEN DAYS

      The Journal of infectious diseases
    29. ERON JJ; ASHBY MA; GIORDANO MF; CHERNOW M; REITER WM; DEEKS SG; LAVELLE JP; CONANT MA; YANGCO BG; PATE PG; TORRES RA; MITSUYASU RT; TWADDELL T
      RANDOMIZED TRIAL OF MNRGP120 HIV-1 VACCINE IN SYMPTOMLESS HIV-1 INFECTION

      Lancet


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/10/20 alle ore 23:22:04